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ABSTRACT 
 
The incorporation of 5-azacytosine residues into DNA causes potent inhibition of DNA 
(Cytosine-C5) methyltransferases. The synthesis of oligodeoxyribonucleotides (ODNs) 
incorporating single or multiple 5-aza-2’-deoxycytidine residues at precise sites of the 
ODN was undertaken to generate an array of sequences containing the reactive 5-
azacytosine base at specific target sites for enzymatic methylation. Preparation of these 
modified oligonucleotides requires the use of 2-(p-nitrophenyl)ethyloxycarbonyl 
(NPEOC) groups for the protection of exocyclic amino functions. These groups are 
removed under mild conditions, thus avoiding conventional protocols that are detrimental 
to the integrity of the 5-azacytosine ring.  
 
 
INTRODUCTION 
 
  5-Azacytosine (ZCyt or Z) is a cytosine analogue wherein the carbon at position 5 
of the pyrimidine ring is replaced by a nitrogen atom. Both ribo- and 2’-deoxyribo-
nucleosides (ZCyd and ZdCyd) versions containing this modified base are potent 
cytotoxic agents which have been used for the treatment of sickle cell anemia, 
myelodysplastic syndrome, leukemia and several other cancers with varying degrees of 
success (Pinto and Zagonel, 1993; Goldberg et al., 1993; Momparler et al., 1997, 
Rochette et al., 1994). As result of their incorporation into DNA, these drugs have a 
unique mechanism of action of demethylating DNA which affects gene regulation 
(Bender et al., 1998; Christman, 1984; Christman et al., 1985; Creusot et al., 1982). In 
order to help elucidate the molecular basis of the inhibitory properties of ZCyt in DNA, 
we have undertaken the preparation of oligodeoxyribonucleotides (ODNs) containing 
ZCyt. The hydrolytic instability of the triazine ring is well documented (Beisler, 1978; 
Lin et al. 1981) and precludes the utilization of standard phosphoramidite protocols 
particularly during the treatment with ammonia.  
 
The preparation of ONDs containing the more stable 5,6-dihydro-5-azacytosine 
base has been described (Goddard and Marquez, 1988),  but conversion of the reduced 
base to ZCyt was not efficient enough to yield the desired ODNs in acceptable yields 
(Goddard and Marquez, 1988). Previous studies (Aviñó et al., 1995) using the H-
phosphonate derivative of ZdCyd without protection of the exocyclic amino group 
showed that the triazine ring was stable to non-nucleophilic bases (such as 1,8-
diazabiciclo[5.4.0]undec-7-ene, DBU) in anhydrous pyridine, conditions under which 
the p-nitrophenylethyl (NPE, Scheme 1) and p-nitrophenylethoxycarbonyl (NPEOC, 
Scheme 1) groups described by Pfleiderer (Himmelsbach et al., 1984) are effectively 
removed (Scheme 2). Unfortunately, the H-phosphonate method was only practical for 
the preparation of short ODN sequences. When ODNs of 15-20 bases were prepared, the 
coupling efficiency of the NPEOC-protected H-phosphonate monomers dropped 
significantly. To overcome this problem, we decided to utilize a modified approach of 
the more conventional phosphoramidite methodology.  
In this communication, we describe the preparation of the NPEOC-protected 
phosphoramidite of ZdCyd and its use in the preparation of longer ONDs containing 
ZCyt. A short description of this work was previously reported (Eritja et al., 1997). 
 
MATERIALS AND METHODS 
 
2'-Deoxy-N4-[2-(4-nitrophenyl)ethoxycarbonyl]-5-azacytidine (2). 
 2'-Deoxy-5-azacytidine (228 mg, 1 mmol) was dried after three successive 
evaporations of a solution in anhydrous pyridine. The residue was dissolved in anhydrous 
DMF and treated with 0.53 ml (2.5 mmol) of hexamethyldisilazane. After stirring 1 h at 
room temperature the solution was concentrated, and the residue was dried by three cycles 
of evaporation from toluene (5 ml) yielding a white foam (TLC, Rf 0.66, 20% ethanol in 
dichloromethane). The residue was then thrice dissolved in 5 ml of anhydrous pyridine 
and concentrated to dryness, before finally dissolving it in 30 ml of anhydrous pyridine. 
To this solution, 350 mg (1.5 mmol) of 2-(p-nitrophenyl)ethyl chloroformate dissolved in 
5 ml of dichloromethane was added, and after 30 min of magnetic stirring at room 
temperature the reaction was judged complete by TLC (Rf 0.93, 10% ethanol in 
dichloromethane). The solution was then concentrated to dryness, and traces of pyridine 
were removed by three cycles of evaporation of a toluene solution (5 ml). The residue was 
dissolved in chloroform and the organic solution was washed with 1M sodium 
bicarbonate, dried (Na2SO4) and concentrated to dryness. 
Removal of the trimethylsilyl groups in DMF solutions. The residue from the above 
reaction was dissolved in DMF/ THF (3:1), and the resulting solution was stirred for 3 
days at room temperature. After the solvents were removed, the residue was triturated 
with ether to form a white solid that was purified by column chromatography on silica gel 
(3 to 10% step gradient of ethanol in chloroform) to give 180 mg (0.43 mmol, 43%) of the 
desylilated product. [TLC (10% ethanol in chloroform) Rf = 0.53; (5% ethanol in 
chloroform) Rf = 0.12]. 1H-NMR (DMSO-d6) δ (ppm): 10.3 (wide s, 1H, NH), 8.41 (s, 
1H, H-6), 7.71 (d, 2H, J= 8.6 Hz, NPEOC), 7.18 (d, 2H, J= 8.6 Hz, NPEOC), 5.56 (t, 1H, 
H-1'), 4.86 (d, 1H, 3'-OH), 4.71 (t, 1H, 5'-OH), 3.92 (t, 2H, CH2 NPEOC) 3.8 (m, 1H, H-
3'), 3.45 (m, 1H, H-4'), 3.17 (m, 2H, H-5'), 2.64 (t, 2H, CH2 NPEOC), 1.8 (m, 2H, H-2'). 
13C-NMR (CDCl3) δ (ppm): 163.0 (C-4), 157.1 (C-6), 153.5 (CO, NPEOC), 150.7 (C-2), 
146.7 (C-NO2), 145.5 (Cq, Ar), 129.9 (CH, Ar), 123.5 (CH, Ar), 87.9 (C-4'), 86.7 (C-1'), 
67.7 (C-3'), 65.4 (CH2), 40.4 (C-2'), 34.6 (CH2). Anal. Calcd. for C17H19N5O8 (Found: C, 
48.1%; H, 4.7%; N, 16.4%; requires C, 48.5%; H, 4.6%; N, 16.6%). 
Removal of the trimethylsilyl groups with TAS-F. Alternatively, the silyl protected product 
resulting from a 4 mmol scale reaction was treated with a solution of tris(dimethylamino) 
sulfonium difluorotrimethylsilicate (TAS-F) (12 mmol, 3.3 mmol) in DMF (50 ml). After 
2 hrs at room temperature, the solution was concentrated to dryness and the residue was 
purified by column chromatography on silica gel as described above to give the same 
product as before (1.35 g, 3.2 mmol, 80%). 
 
2'-Deoxy-5'-O-dimethoxytrityl-N4-[2-(4-nitrophenyl)ethoxycarbonyl]-5-azacytidine (3). 
 2'-Deoxy-N4-[2-(4-nitrophenyl)ethoxycarbonyl]-5-azacytidine (1.63 g, 3.87 mmol) 
was dried after repeated evaporation of a solution in anhydrous pyridine and reacted with 
dimethoxytrityl chloride (1.44 g, 4.26 mmol) in pyridine (20 ml). After 3 hrs stirring at 
room temperature, the solution was concentrated to dryness. Traces of pyridine were 
removed by three cycles of evaporation of a toluene solution (5 ml). The residue was 
dissolved in dichloromethane, and the organic solution was washed with 1M sodium 
bicarbonate aqueous solution, dried (Na2SO4) and concentrated to dryness. The residue 
was purified by column chromatography on silica gel eluted with a 0 to 5% step gradient 
of ethanol in chloroform to give 2.01 g (2.78 mmol, 71%) of 3. [TLC (10% ethanol in 
dichloromethane) Rf = 0.40]. IR (cm-1): 3400, 2960, 1770, 1700, 1610, 1510, 1350, 1250, 
1220, 1180, 1030, 830. 1H-NMR (CDCl3) δ (ppm): 8.60 (s, 1H, H-6), 8.16 (d, 2H, Ar, 
NPEOC) 7.43 (d, 2H, Ar, NPEOC), 7.1-7.3 (m, 9H, Ar, DMT), 6.81 (d, 4H, Ar, DMT), 
6.16 (t, 1H, H-1'), 4.4 (m, 3H, H-3', CH2 NPEOC), 4.2 (m, 1H, H-4'), 3.77 (s, 6H, Me 
DMT), 3.4 (m, 2H, H-5'), 3.1 (t, 2H, CH2 NPEOC), 2.8 (m, 1H, H-2'), 2.3 (m, 1H, H-2'). 
13C-NMR (CDCl3) δ (ppm): 163.1 (C-4), 158.4 (Cq, DMT), 156.8 (C-6), 153.4 (CO, 
NPEOC), 150.2 (C-2), 146.7 (C-NO2), 145.1 (Cq, Ar), 144.2 (Cq, DMT), 135.4 (Cq, 
DMT), 135.2 (Cq, DMT), 129.7 (CH, Ar), 127.8 (CH, DMT), 126.7 (CH DMT), 123.5 
(CH, Ar), 113.1 (CH Ar), 87.7 (C-4'), 86.9 (C-1'), 86.8 (Cq, DMT), 71.2 (C-3'), 65.5 
(CH2), 63.1 (C-5'), 55.0 (CH3), 41.9 (C-2'), 34.5 (CH2).  NOTE: It would have been nice 
to have a better characterization of this compound (Anal. or MS).  
 
N,N-Diisopropylamino-2-(p-nitrophenyl)ethoxy chlorophosphine. 
 In a 1-liter round bottom flask, 17.5 ml (200 mmol) of phosphorous trichloride was 
dissolved in 500 ml of anhydrous acetonitrile and kept under argon atmosphere. The 
solution was cooled over an ice-bath and treated dropwise with a solution of 2-(p-
nitrophenyl)ethanol (3.34 g, 20 mmol) dissolved in 100 ml of acetonitrile. The reaction 
mixture was gradually warmed to room temperature and stirred for 1 hour. The mixture 
was concentrated to give a yellowish oil that was used in the next step without further 
purification. The crude 2-(p-nitrophenyl)ethoxy dichlorophosphine obtained was 
dissolved in 500 ml of acetonitrile, and the solution was cooled with an ice-bath. To this 
solution 6.2 ml (44 mmol) of N,N-diisopropylamine dissolved in 100 ml of acetonitrile 
was added, and after the addition the mixture was gradually warmed to room temperature 
after 6 hours of stirring. The white precipitate was filtered and the filtrate was 
concentrated to dryness to give 5 g (15 mmol, 75%) of a yellowish oil that was used 
directly in the preparation of all phosphoramidites without further purification. 31P-RMN 
δP (75 MHz, CDCl3): 177.74 ppm (90% pure by phosphorous NMR).  
 
Synthesis of the 2-(p-nitrophenyl)ethyl phosphoramidites of the natural bases and 5-
methyl-2’-deoxycytidine.  
 The appropriate 5´-DMT-N,O-(NPEOC, NPE)-protected 2’-deoxynucleoside (2 
mmol) was dried after several coevaporations with dry acetonitrile. The residue was 
dissolved in 50 ml of anhydrous tetrahydrofuran containing 1 ml (6 mmol) of 
diisopropylethylamine. The solution was cooled over an ice-bath and 1.0 g (3 mmol) of 
N,N-diisopropylamino-2-(p-nitrophenyl)ethoxy chlorophosphine was added. After 1 hr 
of magnetic stirring at room temperature, the solution was concentrated to dryness. The 
residue was dissolved in dichloromethane and the organic solution was washed with 1M 
sodium bicarbonate and saturated sodium chloride solutions, dried (Na2SO4) and 
concentrated to dryness. The residue was purified by column chromatography on silica 
gel with ethyl acetate / dichloromethane (1:1). The column was packed with the solvent 
mixture containing 1% triethylamine and eluted with the mixture without triethylamine. 
The appropriate fractions were collected and concentrated to dryness. 
 
3’-O-NPE phosphoramidite of DMT-T: Yield: 83% (1.41g, 1.67 mmol). TLC (ethyl 
acetate / dichloromethane 1:1) Rf = 0.85, 31P-RMN δP (75 MHz, CDCl3): 144.05, 144.43 
ppm.  
 
3’-O-NPE phosphoramidite of DMT-C(NPEOC): Yield: 76% (1.55g, 1.52 mmol). TLC 
(ethyl acetate / dichloromethane 1:1) Rf = 0.78, 31P-RMN δP (75 MHz, CDCl3): 144.62 
ppm. 
 
3’-O-NPE phosphoramidite of DMT-G(NPE, NPEOC): Yield: 79% (1.90g, 1.52 mmol). 
TLC (ethyl acetate / dichloromethane 1:1) Rf = 0.93, 31P-RMN δP (75 MHz, CDCl3): 
143.98 ppm. 
 
3’-O-NPE phosphoramidite of DMT-A(NPEOC): Yield: 77% (1.61g, 1.54 mmol). TLC 
(ethyl acetate / dichloromethane 1:1) Rf = 0.85, 31P-RMN δP (75 MHz, CDCl3): 143.07, 
143.37 ppm. 
 
3’-O-NPE phosphoramidite of DMT-5-methyl-C(NPEOC): Yield: 83% (0.79g, 0.76 
mmol, starting from 0.92 mmol). TLC (ethyl acetate / dichloromethane 1:1) Rf = 0.89, 
31P-RMN δP (75 MHz, CDCl3): 144.42 ppm 
 
 
2'-Deoxy-5'-O-dimethoxytrityl-N4-[2-(4-nitrophenyl)ethoxycarbonyl]-5-azacytidine 3’-O-
(2-(p-nitrophenyl)ethoxy)-N,N-diisopropyl phosphoramidite (4). 
 2'-Deoxy-5'-O-dimethoxytrityl-N4-[2-(4-nitrophenyl)ethoxycarbonyl]-5-azacytidine 
(1 g, 1.38 mmol) was dissolved in anhydrous tetrahydrofuran (35 ml) containing 0.69 ml 
(4.14 mmol) of diisopropylethylamine. The solution was cooled in an ice-bath and 2.04 
mmol of N,N-diisopropylamino-2-(p-nitrophenyl)ethoxy chlorophosphine was added. 
After 1 hr of magnetic stirring at room temperature, the solution was concentrated to 
dryness. The residue was dissolved in dichloromethane and the organic solution was 
washed with 1M sodium bicarbonate and saturated sodium chloride solutions, dried 
(Na2SO4) and concentrated to dryness. The residue was purified by column 
chromatography on silica gel with ethyl acetate / hexane (2:1). The column was packed 
with the solvent mixture containing 1% triethylamine and eluted with the same solvent 
mixture without triethylamine. Yield: 78% (1.0g, 1.08 mmol). TLC (ethyl acetate / 
hexane 2:1) Rf = 0.64, (5% etanol in dichloromethane + 1% triethylamine) Rf = 0.93. 
31P-RMN δP (75 MHz, CDCl3): 145.7 ppm.  
 
Oligodeoxynucleotid e (ODN)  syntheses. 
ONDs were prepared in a 1 μmol scale using phosphoramidite 4 and the 2-(4-
nitrophenyl)ethyl phosphoramidites of the natural bases protected with the NPE and 
NPEOC groups. Controlled-pore glass supports having the NPE,NPEOC-protected 
nucleosides attached through an oxalyl linkage were used (Alul et al., 1991; Aviñó et al., 
1996). Some phosphoramidites were not very soluble in acetonitrile and were dissolved 
in dry dichloromethane to obtain 0.1 M solutions. Standard cycles were used with a 
slight modification of coupling times which were increased from 30 sec to 2 min. 
Coupling efficiencies were >96% as measured by DMT analysis. Deprotection was 
carried out by treatment of the ODN-supports with a 0.5 M DBU solution in pyridine 
containing 5 mg of thymine for 15 hrs at room temperature. The resulting solutions were 
neutralized with acetic acid and concentrated to dryness. The residues were dissolved in 
water and desalted with a Sephadex G-25 or G-10 column.  
Sequences I-V (see Table 1) were prepared with the last DMT group on. 
Purification of these ONDs was performed by HPLC using the following solutions: 
Solvent A: 5% ACN in 100 mM triethylammonium acetate (pH 6.5) and solvent B: 70% 
ACN in 100 mM triethylammonium acetate pH 6.5. Columns: PRP-1 (Hamilton), 250 x 
10 mm. Flow rate: 3 ml/min and a 30 min linear gradient from 10-80% B. Yield (OD 
units at 260 nm after HPLC purification: DMT-heptamer I, 2.2 OD (45 μg); DMT-
octamer II, 6.3 OD (0.18 mg); DMT-15mer III, 15 OD (0.45 mg); DMT-24mer IV, 25 
OD (0.75 mg); and DMT-24mer V, 2.3 OD (80 μg). DMT-ONDs I-V were treated with 1 
ml of acetic acid for 30 min at room temperature. The acetic acid was removed by 
extractions with ether and the ODNs without the DMT group were purified by HPLC 
using similar conditions as before but with a 30 min linear gradient from 0-50% B. Yield 
(OD units at 260 nm after HPLC purification: heptamer I, 0.9 OD (27μg); octamer II, 2 
OD (60 μg); 15mer III, 6 OD (0.18 mg); 24mer IV, 7.5 OD (0.22 mg); and 24mer V, 0.8 
OD (24  μg).  
ODN sequences III, V-XV (see Table 2) were prepared removing the last DMT 
group on the synthesizer and purified by HPLC. Yield (OD units at 260 nm after HPLC 
purification): OND III, 15 OD (0.45 mg); ODN V, 10 OD (0.3 mg); OND VI, 8 OD (0.24 
mg); ODN VII, 14 OD (0.42 mg); ODN VIII, 5 OD (0.15 mg); ODN IX, 9 OD (0.27 
mg); ODN XI, 27 OD (0.81 mg); ODN XII, 15 OD (0.45 mg); ODN XIII, 3 OD ( 90 μg); 
ODN XIV, 45 OD (1.35 mg); and ODN XV, 55 OD (1.65 mg). Five independent 
syntheses (1 μmol each) of sequence X were performed yielding, respectively, 24, 35, 
45, 42 and 21 OD. (NOTE: I changed this for consistency with the previous paragraph) 
Selected ODNs were characterized by mass spectrometry using electrospray 
ionization under neutral conditions. Heptamer I (5’ TAGZTGA 3´) : expected 2120, 
found 2120.4 (M) in addition to peaks at 2110.5 (M-10) and 1830.8 (M-290) plus sodium 
adducts. Octamer II (5’ TAZGZTGA 3’) : expected 2643, found 2642.4 (M) in addition to 
a peak at 2632.4 (M-10) plus sodium adducts. Fifteenmer III: (5’ 
GCAATGGAZCCTCTA 3’) expected 4537, found 4537 (M), in addition to peaks at 4527 
(M-10) and 4236 (M-290) plus sodium adducts. Sequence of 15mer III carrying the DMT 
group (5’ DMT-GCAATGGAZCCTCTA 3’) : expected 4840, found 4839.3 (M), with no 
M-10 and M-290 peaks observed.  Characterization of 24mer ODNs using MALDI-TOF 
was not possible because of fragmentation during acquisition.  
 
Characterization of oligonucleotides (ODNs) by gel electrophoresis. 
ZCyt-ODN XII and the corresponding ODN containing cytosine instead of ZCyt 
were enzymatically radiolabeled with 32P at the 5’-end using T4 kinase and γ 32P-ATP 
[Sambrook et al. 1980]. These ODNs were suspended in TE (10 mM Tris-HCl, pH 7.8, 1 
mM EDTA) and analyzed directly (ss-ZCyt-ODN) or as annealed duplexes (obtained 
after incubation at 60 oC for 60 min, followed by slow cooling to 37 oC) with their 
complementary strands. Twenty ng of ss-ODNs or 40 ng ds-ODNs were suspended in 10 
μL of distilled (twice) water and mixed with 40 μL glacial acetic acid followed by 60 min 
incubation at 37 o for 60 min. For HhaI digestion, 20 ng ss-Cyt-ODN or 40 ng ds-Cyt-
ODN XII were incubated at 37o C for 60 min with 60 U of HhaI in 50 μL NEBuffer 4  
(New England Biolabs, Beverley, MA). Samples in glacial acetic acid were vacuum dried 
in a Savant Speed-Vac and resuspended in 10 μL distilled water containing 0.25% xylene 
cyanol, 0.25% bromphenol blue and 30% glycerol. All other samples were brought to the 
same final concentrations of tracking dyes and glycerol prior to electrophoresis. 8M urea-
20% acrylamide gels were formed and pre-electophoresed for 30 min at 200V in TBE (90 
mM Tris-Borate, pH 8.0, 2 mM EDTA). Samples were also electrophoresed at 200V for 
30 min or until the tracking dye reached the end of the gel. Radiolabeled ODNs in 
vacuum dried gels were detected and quantified by PhosphorImager (Molecular 
Dynamics) analysis. 
 
Melting experiments.  
Equimolar solutions of each complementary pentadecamer (Table 3) dissolved in 50 mM 
Tris-HCl pH 7.5, 0.15 M NaCl were mixed. The resulting solutions were heated to 90 ˚C, 
allowed to cool slowly to room temperature and then samples were kept in the refrigerator 
overnight. UV absorption spectra and melting experiments (absorbance vs temperature) 
were recorded in 1 cm path-length cells using a spectrophotometer equipped with a 
temperature controller with a programmed step increase of 0.5 ˚C/min. Melting curves 
were measured at 260 nm on duplex concentration of 4 μM. 
 
 
RESULTS AND DISCUSSION 
  
Preparation of the NPEOC-protected phosphoramidite of ZCyd. 
We first attempted to prepare the phosphoramidite derivative of 5’-O-dimethoxytrityl-
ZdCyd without protection of the exocyclic amino group. The product was obtained in 
moderate yields; however, coupling of this compound to a growing ODN chain using 
standard phosphoramidite conditions resulted in severe branching after the addition of 
the ZdCyd monomer (data not shown). For this reason, protection of the exocyclic amino 
group was judged necessary and the NPEOC group was selected for this purpose. ZdCyd 
was prepared as described (Piskala and Sorm, 1978), and the introduction of the NPEOC 
at the exocyclic position was performed by the transient protection method (Ti et al., 
1982) (Scheme 3). First, reaction of ZdCyd (1) with hexamethyldisilazane produced the 
silylated nucleoside which was treated with 2-(4-nitrophenyl)ethoxycarbonyl 
chloroformate to give the N4-NPEOC-derivative of 3',5'-O-bis(trimethylsilyl)-ZdCyd. 
The removal of the trimethylsilyl groups without destroying the base was the critical step 
on this approach. Use of tetrabutylammonium fluoride, ammonium fluoride, sodium 
ethoxide, p-toluensulfonic acid or acetic acid effectively removed the silyl groups, but 
also caused the breakdown of the base. However, a gradual but complete removal of the 
silyl groups without detectable side reactions was achieved after maintaining the solution 
of the silylated nucleoside in DMF for 4 days at room temperature. Using this method, 
the NPEOC-protected nucleoside (2) was obtained in 43% yield after silica gel 
purification. Finally, it was discovered that the trimethylsilyl groups could be removed 
more efficiently using tris(dimethylamino) sulfonium difluorotrimethylsilicate (TAS-F) 
(Scheidt et al., 1998). This source of fluoride was able to effectively remove the 
trimethylsilyl groups and the desired product 2 was obtained in 80% yield after silica gel 
purification. 
Reaction of 2 with DMT-Cl followed by reaction with the appropriate 
chlorophosphine gave the desired phosphoramidite (4) in good yields. During all these 
reactions, special care was taken to eliminate traces of pyridine before any aqueous 
work-up. Failure to do so resulted in complete degradation of the nucleoside. 
The rest of the phosphoramidites corresponding to the natural bases protected with 
the NPE and NPEOC groups (Scheme 4) were prepared following previously described 
protocols (Himmelsbach et al., 1984; Aviñó and Eritja, 1994; Díaz et al., 1997), 
including the NPE-phosphoramidite of 5-methyl-2’deoxycytidine (M) protected with the 
NPEOC group (Ferrer et al., 1996). 
 
Synthesis of the oligodeoxyribonucleotides  (ODNs) containing 5-azacytosine (ZCyt). 
 ODN sequences ranging from 7 to 24 nucleotides (I-XV, Tables 1 and 2) were 
prepared. Heptamer I and octamer II are two small sequences that were used for full 
characterization and detailed analysis. Pentadecamer III and mismatched variants (Table 
3) were synthesized to study the hybridization properties and stability of the ODNs 
carrying ZCyt. ODN sequences with 24 bases (IV-IX, XII-XV) were designed to contain 
target sequences for DNA (Cytosine-C5) methyltransferases. Comparable sequences had 
been used previously for the characterization of the inhibitory properties of ODNs 
containing 5,6-dihydro-5-azacytosine (Marquez et al., 1999; Sheikhnejad et al., 1999). 
Finally, 13mers X and XI, with similar target sequences for methylation, were prepared 
for future co-crystallization studies with the M.HhaI, a bacterial DNA (Cytosine-C5) 
methyltransferase. All ODNs were synthesized in 1 μmol scale using phosphoramidite 4 
and the NPE phosphoramidites of the natural bases protected with the NPE and NPEOC 
groups (Scheme 4). Controlled-pore glass (CPG) supports having the NPE, NPEOC-
protected nucleosides attached through an oxalyl linkage were used (Alul et al., 1991). 
The oxalyl bond is efficiently cleaved by DBU solutions with higher efficiency (Aviñó et 
al., 1996) than the previously described NPE linkage (Eritja et al., 1992). Coupling 
efficiencies judged by the absorbance of the DMT cation released during detritylation 
were greater than 96%.  
Initially, syntheses of sequences I-V were performed. To facilitate purification the 
last DMT group on the ODN was left on. Deprotection was carried out by treatment of 
ODN-supports with a 0.5 M DBU solution in pyridine containing 5 mg of thymine for 15 
hours at room temperature (Aviñó and Eritja, 1994; Aviñó et al., 1996). Purification of 
the final products was performed by HPLC using the standard DMT-on and DMT-off 
protocols. HPLC chromatograms were similar to those of unmodified ODNs but yields 
were lower and variable (0.8-7.5 O.D. units, see Table 1). For comparison, one may 
expect about 30-40 OD units for a 20mer in a 1 μmol synthesis. Lower yields could be 
attributed to a less efficient cleavage from the linkage  ODN-support (Aviñó et al., 1996), 
or to the observed drop (50% or more) in the recovery of product after removal of the 
DMT with acetic acid (Table 1). This loss of product was initially thought to result from 
the instability of the 5-azacytosine ring during acetic acid treatment to remove the DMT 
group. However, no degradation products (shorter ODNs) were detected by gel 
electrophoresis after treatment with acetic acid (vide infra).  
Characterization of the products obtained was attempted by enzymatic digestion 
and mass spectrometry. Enzymatic digestion (NOTE: Specify what enzyme was used for 
this digestion and some description of the process should be included in the Experimental 
Section) was used first to characterize ODNs I and II.  After enzyme treatment no ZdCyd 
was detected, even though ODNs I and II do not contain any dC that could co-elute with 
ZdCyd and mask its presence. Thus, it appeared that the most probable cause for the 
absence of detectable ZCyd was nucleoside degradation during incubation and enzymatic 
digestion at pH 8.5 (Beisler, 1978, Lin et al., 1981). 
Electrospray ionization mass spectrometry analysis under neutral conditions gave 
the expected molecular weights for ODNs I-III, thus confirming both the integrity of the 
ODN and that indeed degradation of 5-aza-2’-deoxycytidine happened during the 
enzymatic digestion. Special care was taken to avoid acids or bases during the 
acquisition of the spectra, which could cause the degradation of the sensitive base. 
Although electrospray ionization under neutral conditions gave clear molecular ion peaks 
for ODNs I-III, along with the peaks corresponding to the sodium adducts, it failed to 
give the expected molecular ion peaks for the 24mers. In addition to the expected 
molecular weights, analysis of purified ODNs I-III also showed the presence of small 
amounts of two other components: one having 10 amu units (or Daltons) less than the 
expected mass (M-10) and a second unknown peak 290 amu units less (M-290). The M-
10 product was presumed to result from the opening of the hydrated ZCyt ring with 
subsequent loss of a formyl group (Scheme 5). Such spontaneous ring opening and loss 
of a formyl group has been observed in ZCyt derivatives (Beisler, 1978; Lin et al., 1981) 
and in 5-aza-2’-deoxycytidine-thymine dimers (Goddard and Marquez, 1989). The M-
290 peak, on the other hand, is difficult to explain since it corresponds to an ODN that is 
missing a dideoxydidehydro-5-azacytidine phosphate unit (C8H11N4O6P) altogether! 
Since coupling yields with 5-aza-2'-deoxycytidine phosphoramidite were high, and the 
capping step should have prevented the elongation of unreacted sequences, the M-10 and 
M-290 products could have resulted from the degradation of the unstable ZdCyd ring 
opening either under oxidation or detritylation conditions during ODN synthesis. 
However, mass spectrometric analysis of the DMT-oligonucleotide III showed the 
absence of M-10 and M-290 peaks, and only following the removal of the DMT with 
acetic acid and ion exchange HPLC purification these peaks were observed. Although 
this two-step protocol led to the enrichment of the impurities relative to the desired 
product, we can only explain the origin of the M-10 peak. (NOTE: The M-290 peak 
implies that a dideoxydidehydro-5-azacytidine phosphate unit was plucked out of the 
middle of the strand and the ODN was reconnected. That is hard to postulate specially in 
view of the lack of cleavage observed in gels after acetic acid treatment.  I think Judy has 
a good point here and  we should simply say that we don’t understand). Characterization 
of 24-mers ODNs was not possible using MALDI-TOF because the larger ODNs 
fragmented during the spectral adquisition.  
Stability of ODNs III and XII was monitored by gel electrophoresis (Figures 1 and 
2). This technique confirmed that ZCyt-ODNs were stable in water in neutral pH (for at 
least 48 hours). Overnight treatment with concentrated ammonia at 55 ºC caused 
complete breakdown of the ODNs into two shorter sequences, as would be expected if 
scission occurred at ZCyt residue (Figure 1). Products coming from the acetic acid 
treatment did not stain with ethidium bromide (Figure 1). Therefore, to obtain a better 
picture of the effect of acetic acid on ZCyt-ODNs, 5’-32P-radiolabeled single stranded 
(ss) ODNs and double stranded (ds) ODNs formed after annealing with the 
complementary  strand were incubated in 80% acetic acid at 37o for 30-60 min and 
analyzed by electrophoresis on 8M urea-20% polyacrylamide gels. The result of a typical 
treatment is shown in Figure 2. The mobility of the acetic acid treated ODN XII (Lanes 
1-3) was compared with that of an ODN of identical sequence but with cytosine 
replacing ZCyt (Cyt-oligonucleotide), before (Lanes 4, 5) or after cleavage with HhaI 
(Lane 6). The Cyt-ODN treated with HhaI serves as a control for any breakdown of a 
standard ODN during acetic acid treatment. Since the ZCyt in ODN XII is in the 
recognition/cleavage site for HhaI, the cleaved Cyt-ODN serves as a molecular marker 
for an ODN 8 bases long. As can be seen, whether treated as a single-strand (ss) ODN or 
after annealing with a complementary ODN to form a double stranded (ds) ODN, little 
general breakdown of full-length ODN XII occurs after a 60 min treatment with acetic 
acid. Only a small proportion of the ODN appears to be converted to fragments of a size 
(6 bases long) expected for scission at the ZCyt residue (compare Lanes 2, 3 with Lane 
6). These results suggest that even if opening of the ZCyt ring occurs, decomposition to a 
form that results in the scission of the phosphodiester bond does not occur rapidly under 
acidic conditions. These results are in contrast with the reported instability of ZCyd and 
ZdCyd (Beisler, 1978; Lin et al., 1981), which leads us to conclude that ZCyt is more 
stable inside the ODN polymer than as a free nucleoside. Although it can be argued that 
the direct decomposition of the base could not be detected by gel analysis, the results 
obtained with the ammonia treatment indicate that we could detect the breakdown at the 
ODN abasic DNA site resulting from the elimination of ZCyt (Scheme 5). 
Due to the poor recovery of ODN containing ZCyt after treatment with acetic acid, 
ODN sequences III and VI-XV were prepared without the last DMT group and purified 
directly using reversed-HPLC DMT-off conditions (Table 2). Purity of the ODNs was 
monitored by gel electrophoresis and in all cases they appeared to be homogeneous. 
Three oligonucleotides (XIII, XIV and XV) also contained 5-methyl-cytosine (M). In 
these cases, the appropriate monomer carrying the NPEOC group was utilized. 
 A strong correlation between yield of ODN and the nature of the nucleoside present 
at the 3’-end was observed (Table 2). Thus, ODNs V, VI, VII, VIII, IX, XII and XIII, all 
of which have pyrimidines at the 3’-end were obtained in poorer yields (3-15 OD units). 
ODNs having purines at the 3’-end, on the other hand, were obtained in much better 
yields: 24-45 OD units of ODN sequences having a G at the 3’-end (X and XII) and 15-
55 OD units of oligonucleotides having A at the 3’-end (III, XIV and XV). The proposed 
mechanism of cleavage for the oxalyl bond is a base-catalyzed intramolecular attack of 
the amide group onto the ester bond at the 3’-end of the ODN (Scheme 6) (Aviñó et al., 
1996). Thus, it is possible that different steric or inductive effects related to the nature of 
base might influence the reactivity of the oxalyl group. In our specific case, ease of 
cleavage of the oxalyl group with DBU followed the order G>A>T>C. At the 5’-end, a 
similar base-dependent reactivity has been observed for DMT groups towards acid 
cleavage. Indeed, it is well known that the lability of the DMT groups towards acid 
cleavage follows the order G >A >>T =C (Atkinson and Smith, 1984). In order to 
improve the yields, the hydroquinone-O,O-diacetic acid (Q-linker) (Pon and Yu, 1997) 
was investigated. This linker is resistant to DBU solutions but cleavable with very mild 
nucleophiles. Unfortunately, following treatment with DBU, a brief exposure with a mild 
source of fluoride ions (i.e. triethylamine trihydrofluoride in N-methylpyrrolidone or 
DMSO) failed. 
 
Melting experiments. 
 The base-pairing properties of 5-azacytosine were measured on a duplex formed by 
two complementary pentadecamers in which ZCyt was paired with the four natural bases 
(Table 3). As expected, ZCyt formed the strongest base pair with G, although the Z:G 
base pair is 9 ºC less stable than the natural C:G base pair. Mismatches of Z are also less 
stable than C mismatches (ca. 3 °C) except for Z:C, which is as stable as the C:C 
mismatch. The strong decrease in melting temperature observed for the Z:G base pair 
could be due to the 5-azacytosine ring being involved in rapid equilibrium between syn 
and anti conformations in which the former rotamer is unable to hydrogen bond 
effectively with G via the carbonyl group at C-2. It is also likely that if the ODN is 
heated to 90 ºC during the preparation of the duplex the ZCyt may undergo ring opening 
and loss of formate. In order to estimate the impact of this potential decomposition 
during heating, five consecutive melting curves were recorded. We observed that the 
melting curve reproduced well after each heating cycle but with a small decrease in 
melting temperature of approximately 1 ºC per cycle. Thus, we can conclude that a small 
decomposition of ZCyt may occur during each cycle and that the melting temperatures 
reported in Table 3 may be at least one degree lower than the real melting temperature.  
 
Conclusions 
 In this paper, we describe the preparation of the phosphoramidite derivative of 5-
aza-2'-deoxycytidine protected with the NPEOC group. This phosphoramidite allows the 
efficient preparation of ODNs containing ZCyt provided that mild, non-hydrolytic 
conditions are used during the removal of the NPE, NPEOC groups. The extreme lability 
of the Z interferes not only with the preparation of the protected phosphoramidite and the 
removal of the protecting groups, but also with the purification of the modified 
oligonucleotides. In spite of these drawbacks, we have successfully prepared several 
ODNs containing one or more ZCyt units that have the appropriate length and purity 
required for biological studies. A report studying the inhibitory properties of these ZCyt-
modified oligonucleotides against DNA methyltransferase has been submitted (Brank et 
al., submitted). We have observed that yields of ODNs are dependent on the nature of the 
nucleoside present at the 3’-end, probably due to a lower efficiency in the cleavage from 
the ODN-support linkage. Therefore, a good alternative for a future investigation is the 
use of photolabile linkers (Greenberg and Gilmore, 1994). The results presented here are 
of special interest for the preparation of ODNs carrying sensitive molecules such as 
mutagenic or reactive bases (Aviñó et al., 1995), or labile internucleotide bonds (Vivès et 
el., 1999).   
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Figure and scheme legends. 
 
Scheme 1. The NPEOC and the NPE protecting groups. 
 
Scheme 2. Mechanism of removal of the NPEOC protecting group by non-nucleophilic 
bases. 
 
Scheme 3. Preparation of the phosphoramidite of 5-aza-2’-deoxycytidine. DMT: 
dimethoxytrityl, NPEOC: 2-(p-nitrophenyl)ethoxycarbonyl, TMS: trimethylsilyl. 
 
Scheme 4. Preparation and structures of the phosphoramidites and solid supports used in 
this work.  
 
Scheme 5.  Proposed pathway for the decomposition of 5-azacytosine in DNA as 
described for the free nucleoside (Beisler 1978; Lin et al., 1981).  
 
Scheme 6. Proposed mechanism for the cleavage of the oxalyl linker by 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU). CPG: controlled pore glass. 
 
FIG 1. Effect of ammonia and acetic acid on the integrity of ODNs containing ZCyt. 
Reactions containing 0.1 OD units of ODN III were incubated overnight with 
concentrated ammonia at room temperature (Lane 2) and at 55 ºC (Lane 3), and with 
80% acetic acid (1hour) at room temperature (Lane 4). Following these treatments, the 
samples were concentrated to dryness. Samples were analyzed on a 20% acrylamide / 
7M urea gel. Bands were visualized with ethidium bromide and UV-shadowing (Lane 4 
did not stain well with ethidium bromide). Lane 1 show the migration of untreated ODN 
III and Lane 3 show the migration of a control ODN which has the same sequence than 
ODN III but containing cytosine instead of ZCyt. 
 
FIG 2. 8M Urea-20% polyacrylamide gel electrophoretic analysis of ZCyt- and Cyt-
ODNs after exposure to 80% acetic acid at 37 oC for 60 min. Lane 1, ss-ZCyt-ODN 
(control-no treatment); Lane 2, ss-ZCyt-ODN (acid treated); Lane 3, ds-ZCyt (acid 
treated); Lane 4, ss-Cyt-ODN (acid treated); Lane 5, ds-Cyt-ODN (acid treated); Lane 6, 
ss-Cyt-ODN and Lane 7, ds-Cyt-ODN incubated with HhaI. Cleavage with this 
restriction endonuclease yields a radiolabeled fragment 8 bases long (arrow).  A 
radiolabeled scission product 5’ to ZCyt would be 6 bases long.  Experimental details 
are presented in Material and Methods. 
Table 1: 5-Azacytosine (Z) ODNs prepared using two-HPLC steps (DMT-on and DMT-
off). 
 
Sequences (5’->3’) OD units after first 
HPLC (DMT-on) 
OD units after 
second HPLC 
(DMT-off) 
I TAGZTGA 2.5 0.9 
II TAZGZTGA 6.3 2 
III GCAATGGAZCCTCTA 15 6 
IV ATTGCGCATTCCGGATCZGCGATC 25 7.5 
V ATTGCGCATTCCGGATCCGZGATC 2.3 0.8 
 
 
 
Table 2: ODN sequences having 5-azacytosine prepared in this work using one-step 
purification by HPLC (Z= 5-azacytosine, M= 5-methylcytosine). 
 
Sequence (5’-> 3’) OD units after HPLC 
III GCAATGGAZCCTCTA   15 
V ATTGCGCATTCCGGATCCGZGATC 10 
VI ATTGZCCATTCCGGATCCGCGATC   8 
VII ATTGCCCATTCZGGATCCGCGATC   14 
VIII ATTGZCCATTCZGATCZGZGATC 5 
IX ATTGCCCATTZCGGATCCGCGATC 9 
X TGTCAGZGCATGG   24,35,45,42,21 
XI TGTCAGCGZATGG   27 
XII TGTCAGZGCATGGATGGTTATAAT 15 
XIII ATTGCCMATTCCGGATCZGCGATC 3 
XIVATGAGCMAAAAAAAAAAZGGCTCA 45 
XV ATGAGZMAAAAAAAAAACGGCTCA 55 
 
Table 3. Melting temperatures (ºC) of duplexes containing 5-aza-2’-deoxycytidine 
(ZCyt) base pairs (0.15 M NaCl, 0.05 M Tris-HCl buffer, pH 7.5) 
 
5’ GCAATGGAXCCTCTA 3’ 
3’ CGTTACCTYGGAGAT5’ 
 
 X = Z X = C 
Y = G 50 59 
Y = A 44 47 
Y = C 45 45 
Y= T 43 46 
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